VIPR1 and rheumatoid arthritis: Given the ability of VIP to regulate the intensity of the inflammatory process and the immune response, together with the particular expression pattern of VIP receptors in RA, we hypothesized that expression of VPAC1 and VPAC2 might be associated with disease activity and would thus reflect the patient’s clinical status.